Investment opportunity

We are looking for funding in order to move forward with our next clinical trial. Read more below.

Investment opportunity

Management Team

The Management Team consists of the CEO and other members appointed by the Board of Directors. Our capable management team consists of five people, including the CEO, CMO, CFO, CSO, and COO.

Adrian Harel

Dr. Adrian Harel

Chief Executive Officer (CEO), founder of Medicortex, and Chairman of the Board

Chief Executive Officer since: 2014

About: Dr. Harel, has a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University. Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Dr. Harel has extensive Drug R&D know-how and GMP production and manufacturing knowledge. He combines a broad scientific education with extensive industry experience. See more at 'Board of Directors'.


Marten Kvist

Dr. Mårten Kvist

Chief Medical Officer (CMO) and board member

Chief Medical Officer since: 2021 (before that: 'Medical Director' since 2015)

About: Dr.Kvist has an MD from the University of Helsinki, Finland, and MD/PhD from the University of Turku, Finland. He is also an Associate Professor (Docent) in General Practice at the University of Turku and in public Health at the University of Lapland.Dr. Kvist has been the CMO at Medicortex since 2014. See more at 'Board of Directors'.


Mikko Laurila

Mikko Laurila

Chief Financial Officer (CFO)

Chief Financial Officer since: 2022

About: Mikko Laurila has a MSc degree in Economics, and has worked as the CFO at Medicortex since 2022. He is an experienced finance professional, with extensive experience in corporate finance, M&A, business development and reporting. Mr. Laurila has listed company background both in-house as well as an external advisor. He´s the founder of Railo Partners, which offers strategic financial services. Additionally, he has several statutory director roles abroad, and is involved in various projects with other stock listed companies, mainly in the field of M&A and business development.


Lasse Valimaa

Dr. Lasse Välimaa

Chief Scientific Officer (CSO)

Chief Scientific Officer since: 2021 (before that: 'Head of R&D' since 2015)

About: Dr. Välimaa, the head of R&D since 2015, has a PhD degree in Molecular Biotechnology and Diagnostics at the University of Turku, Finland. His background is in the R&D of bioanalytical methods and medical diagnostics. Dr. Välimaa has diagnostic assay development practical experience, as well as analytical and biochemical knowledge and hands-on experience. At Medicortex, Dr. Välimaa is involved in a wide range of study activities, covering, inter alia, clinical protocol preparation, sample analysis management, results analysis and development of detection methods. His role will range from supervising and coordinating study activities to hands-on work with samples and laboratory experiments. In his previous academic positions as a Researcher and Project Manager, he addressed several technical features influencing the performance of biochemical binding assays.


Oskar Haavisto

Oskar Haavisto

Chief Operating Officer (COO)

Chief Operating Officer since: 2021 (before that: 'Research Coordinator' since 2018)

About: Oskar Haavisto has a MSc degree in Molecular Biotechnology and Diagnostics at the University of Turku, Finland. He has been operating as the COO at Medicortex since 2018. Mr. Haavisto has practical experience and scientific know-how in the diagnostic immunoassay field and therapeutic antibody development. He has prior experience in coordinating scientific research projects, and has previously worked as a clinical research coordinator.